Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?

Immunol Today. 1998 Jan;19(1):2-5. doi: 10.1016/s0167-5699(97)01191-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Immunotherapy*
  • Neoplasms / therapy*
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • Antibodies, Monoclonal